GoodRx Reports Fourth Quarter and Full Year 2024 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- Tesla acquires AI hardware company for up to $2 billion in stock
Raymond James Reiterates Strong Buy Rating on GoodRx Holdings Inc. (GDRX)
February 27, 2025 4:05 PM ESTRaymond James analyst Aaron Kessler reiterated a Strong Buy rating and $9.00 price target on GoodRx Holdings Inc. (NASDAQ: GDRX).
The analyst comments "All in all, it was a solid quarter, and we expect a more stable cadence of expectations/earnings... More
GoodRx Holdings Inc. (GDRX) PT Raised to $6.75 at Citi
February 27, 2025 3:15 PM ESTCiti analyst Daniel Grosslight raised the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $6.75 (from $6.25) while maintaining a Buy rating.
The analyst comments "After a couple quarters of excess volatility, GDRXs 4Q results should be a bit of a reprieve for... More
